Showing results (51-60 of 84) with videos related to
Sort By:
Pageof 9
JCI Insight|September 24, 2020
Assessment of HIV-1 integration in tissues and subsets across infection stagesVincent H Wu, Christopher L Nobles, Leticia Kuri-Cervantes, et al.AIDS (London, England)|March 25, 2020
Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohortNuttada Panpradist, Ingrid A Beck, Parker S Ruth, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2020
Dynamics and Dispersal of Local Human Immunodeficiency Virus Epidemics Within San Diego and Across the San Diego-Tijuana BorderBram Vrancken, Sanjay R Mehta, Santiago Ávila-Ríos, et al.Plos One|March 17, 2022
Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico CityVanessa Dávila-Conn, Maribel Soto-Nava, Yanink N Caro-Vega, et al.The Journal of Antimicrobial Chemotherapy|November 18, 2024
Pretreatment and acquired HIV drug resistance in Belize-results of nationally representative surveys, 2021-22Francis Morey, Amalia Girón-Callejas, Russell Manzanero, et al.Vaccines|December 23, 2022
Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal OutcomesRicardo Serna-Muñoz, Alejandra Hernández-Terán, Maribel Soto-Nava, et al.Journal of the International AIDS Society|December 21, 2019
High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016Amalia Girón-Callejas, Claudia García-Morales, Ricardo Mendizabal-Burastero, et al.Cancers|October 16, 2025
Correction: Rodríguez-Bautista et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. <i>Cancers</i> 2021, <i>13</i>, 6256Rubén Rodríguez-Bautista, Claudia H Caro-Sánchez, Paula Cabrera-Galeana, et al.Mbio|March 30, 2026
HIV Nef-mediated WAVE2-ARP2/3 inhibition underlies CD4<sup>+</sup> T-cell lamellipodial abnormalities and immune dysfunctionDaniel C Dunn, Jacqueline M Crater, Perla M Del Río Estrada, et al.The Journal of Antimicrobial Chemotherapy|December 11, 2019
Pretreatment HIV drug resistance spread within transmission clusters in Mexico CityMargarita Matías-Florentino, Antoine Chaillon, Santiago Ávila-Ríos, et al.Pageof 9